BioSpace News Archive

Business

OPKO Health Announces Leadership Changes at BioReference Laboratories

The Company has begun a search for his replacement and, in the interim, a committee of senior management will assume operational responsibilities.

January 26, 2018
·
3 min read
Pharm Country

Insmed Announces Closing of Public Offering - Jan. 26, 2018

The net proceeds to Insmed from the offering were approximately $435.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Insmed.

January 26, 2018
·
10 min read
FDA

Novartis’ Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera

The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy.

January 26, 2018
·
14 min read
FDA

Perrigo Announces Tentative FDA Approval for the Generic Version of Onexton Gel

Onexton Gel is a prescription medicine indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

January 26, 2018
·
4 min read
BioMidwest

Sensient Announces Conference Call on February 9, 2018

Sensient Technologies Corporation will hold its conference call to discuss 2017 fourth quarter and year end results at 10:00 a.m. CST on Friday, February 9, 2018.

January 26, 2018
·
1 min read
Primus Announces a Voluntary Nationwide Recall of All Lots Within Expiry of Prescription Medical Food Limbrel Due to Rare But Serious and Reversible Adverse Events

Primus is notifying its distributors by emailed letter and is arranging for the return of all recalled products.

January 26, 2018
·
4 min read
BioMidwest

Sensient Declares Dividend

The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.33 per share.

January 26, 2018
·
1 min read
Deals

CASI Pharma Acquires ANDA Portfolio From Sandoz

CASI intends to select and commercialize certain products from the portfolio that have unique market opportunity and cost-effective manufacturing in China and/or in the U.S.

January 26, 2018
·
5 min read
Biotech Beach

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Innovus Pharmaceuticals announces that it was made aware of and requested by the OTC Markets Group Inc. to comment on recent market activity concerning shares of INNV common stock.

January 26, 2018
·
5 min read